Share:
Amid required stay-at-home orders, many have paused or canceled doctor’s appointments over the past 12 months. Recent studies show some of the troubling effects of patients missing out on treatments for vision loss. Alimera Sciences believes it has a solution.
A Daily Microdose
Recently, the Cleveland Clinic published a paper, “The Effect of Delay in Care Among Patients Requiring Intravitreal Injections,” regarding the results of patients missing their prescribed vision loss treatments due to the COVID pandemic.
This 1,041-patient retrospective analysis examined the effect of a delay in care on the visual acuity of patients requiring intravitreal injections. The authors looked at patients with retina disease who had received an intravitreal injection in the 12-week period prior to March 14, 2020 (start of the lockdowns).